File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/molecules28041756
- Scopus: eid_2-s2.0-85149053659
- WOS: WOS:000940970300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids
Title | A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids |
---|---|
Authors | |
Keywords | Ganoderma lucidum lucidenic acids pharmacological effects |
Issue Date | 12-Feb-2023 |
Publisher | MDPI |
Citation | Molecules, 2023, v. 28, n. 4 How to Cite? |
Abstract | Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals. |
Persistent Identifier | http://hdl.handle.net/10722/328999 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 0.744 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zheng, Chengwen | - |
dc.contributor.author | Rangsinth, Panthakarn | - |
dc.contributor.author | Shiu, Ho Ting | - |
dc.contributor.author | Wang, Wen | - |
dc.contributor.author | Li, Renkai | - |
dc.contributor.author | Li, Jingjing | - |
dc.contributor.author | Kwan, Yiu Wa | - |
dc.contributor.author | Leung, George Pak Heng | - |
dc.date.accessioned | 2023-08-05T07:54:31Z | - |
dc.date.available | 2023-08-05T07:54:31Z | - |
dc.date.issued | 2023-02-12 | - |
dc.identifier.citation | Molecules, 2023, v. 28, n. 4 | - |
dc.identifier.issn | 1420-3049 | - |
dc.identifier.uri | http://hdl.handle.net/10722/328999 | - |
dc.description.abstract | <p>Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals.</p> | - |
dc.language | eng | - |
dc.publisher | MDPI | - |
dc.relation.ispartof | Molecules | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Ganoderma lucidum | - |
dc.subject | lucidenic acids | - |
dc.subject | pharmacological effects | - |
dc.title | A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/molecules28041756 | - |
dc.identifier.scopus | eid_2-s2.0-85149053659 | - |
dc.identifier.volume | 28 | - |
dc.identifier.issue | 4 | - |
dc.identifier.eissn | 1420-3049 | - |
dc.identifier.isi | WOS:000940970300001 | - |
dc.identifier.issnl | 1420-3049 | - |